Vinayak, Shaveta
34  results:
Search for persons X
?
2

Identifying homologous recombination deficiency in breast c..:

Lenz, Lauren ; Neff, Chris ; Solimeno, Cara...
Breast Cancer Research and Treatment.  202 (2023)  1 - p. 191-201 , 2023
 
?
3

Emerging strategies: PARP inhibitors in combination with im..:

Gupta, Tanya ; Vinayak, Shaveta ; Telli, Melinda
Breast Cancer Research and Treatment.  197 (2022)  1 - p. 51-56 , 2022
 
?
4

Selection of Adjuvant Endocrine Therapy for Women With Brea..:

Vinayak, Shaveta ; Davidson, Nancy E
JNCI: Journal of the National Cancer Institute.  113 (2021)  11 - p. 1444-1446 , 2021
 
?
6

Homologous recombination deficiency (HRD) status predicts r..:

Telli, Melinda L. ; Hellyer, Jessica ; Audeh, William...
Breast Cancer Research and Treatment.  168 (2017)  3 - p. 625-630 , 2017
 
?
7

Interferon-beta represses cancer stem cell properties in tr..:

Doherty, Mary R. ; Cheon, HyeonJoo ; Junk, Damian J....
Proceedings of the National Academy of Sciences.  114 (2017)  52 - p. 13792-13797 , 2017
 
?
9

Interferon-beta represses cancer stem cell properties in tr..:

Doherty, Mary R. ; Cheon, HyeonJoo ; Junk, Damian J....
Proceedings of the National Academy of Sciences of the United States of America.  114 (2017)  52 - p. 13792-13797 , 2017
 
?
11

A clinical trial of lovastatin for modification of biomarke..:

Vinayak, Shaveta ; Schwartz, Erich J. ; Jensen, Kristin...
Breast Cancer Research and Treatment.  142 (2013)  2 - p. 389-398 , 2013
 
?
12

PARP Inhibitors for the Treatment and Prevention of Breast ..:

Vinayak, Shaveta ; Ford, James M.
Current Breast Cancer Reports.  2 (2010)  4 - p. 190-197 , 2010
 
?
 
?
 
1-15